Accelerated Approval, Clinical Trial Diversity Provisions Left Out Of Senate User Fee Bill

Capitol ven diagram
There's not much overlap in the content of the House and Senate user fee bills. • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock image
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from User Fees

More from Pathways & Standards